DiNAQOR has developed a proprietary technology platform and manufacturing capabilities designed to overcome the challenges and limitations of early-stage gene therapy development.

Products, services, technology

Our platform consists of three core components: our human-based engineered heart tissue (EHT) technology; our LRP System which enables organ-specific delivery of gene therapies; and DiNAMIQS, our Contract Development and Manufacturing Organization based in Schlieren-Zürich.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business

You may also be interested in